News
Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people, but a new ...
We have carefully reviewed the article titled ‘Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study’ by ...
Abstract. Main Goals: Evaluation and comparison of short-term results of totally laparoscopic gastrectomy performed for gastric carcinoma in two groups of patients: older and younger than eighty years ...
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...
14d
Sportschosun on MSNGastric cancer patients recover faster after surgery, less painResearchers at Seoul National University Hospital applied 'Enhanced Recovery After Surgery (ERAS)' to gastric cancer surgery patients using laparoscopy or robots, and found that the quality of ...
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer By Angus Liu Jun 9, 2025 10:50am Merck & Co. Keytruda Bristol Myers Squibb Opdivo ...
aBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, ...
Keywords: gastric cancer, immunotherapy, apatinib, survival time, prognosis, antiangiogenesis. Citation: Zhu P-F, Yang L and Chen Z-L (2025) The evaluation of the efficacy and safety about apatinib ...
Overall net promoter score was 32%, with 48% promoters, 36% passives, and 16% detractors, indicating that participants were likely to recommend the applet to others. A specialized nutrition ...
Introduction. Gastric cancer (GC) is the fifth most prevalent malignancy worldwide (), with a generally poor prognosis ().Following the landmark MAGIC trial (3–5), neoadjuvant therapy (NAT) has been ...
3. Janjigian Y., et al. N Engl J Med 2025; Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. DOI: 10.1056/NEJMoa2503701. 4. Imfinzi plus chemotherapy more than doubled ...
According to the latest data presented at ASCO, it could be pivotal in addressing early-stage stomach cancer. When given along with chemotherapy before and after surgery to patients with early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results